Drug intelligence / Profile preview

MyZyme

Development stage: Unknown
Lead developer: 4Potentia
Modality: Recombinant Proteins and Enzymes, Peptides
Administration: Oral

Overview

MyZyme is a proprietary, natural enzyme blend developed by 4Potentia, designed as a dietary supplement ingredient to optimize protein digestion and amino acid absorption. By facilitating the breakdown of dietary proteins into bioavailable peptides and amino acids, MyZyme aims to enhance muscle protein synthesis, accelerate recovery, and improve overall metabolic efficiency. It is primarily marketed for inclusion in sports nutrition products, such as protein powders and recovery formulas, to maximize the nutritional value of protein intake and support muscle health in active individuals and those managing age-related muscle loss.

Brand names: MyZyme
Other names: MyZyme™

Beyond the preview

Go deeper on MyZyme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MyZyme.

Explore the full profile